95 related articles for article (PubMed ID: 7542815)
21. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
[TBL] [Abstract][Full Text] [Related]
22. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
[TBL] [Abstract][Full Text] [Related]
23. Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia.
Ryan AS; Egan JM; Habener JF; Elahi D
J Clin Endocrinol Metab; 1998 Jul; 83(7):2399-404. PubMed ID: 9661618
[TBL] [Abstract][Full Text] [Related]
24. Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.
Højberg PV; Vilsbøll T; Zander M; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S
Diabet Med; 2008 Nov; 25(11):1268-75. PubMed ID: 19046215
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamics and pharmacokinetics of insulin aspart assessed by use of the isoglycemic clamp method in healthy cats.
Pipe-Martin HN; Fletcher JM; Gilor C; Mitchell MA
Domest Anim Endocrinol; 2018 Jan; 62():60-66. PubMed ID: 29101821
[TBL] [Abstract][Full Text] [Related]
27. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.
Stumvoll M; Mitrakou A; Pimenta W; Jenssen T; Yki-Järvinen H; Van Haeften T; Renn W; Gerich J
Diabetes Care; 2000 Mar; 23(3):295-301. PubMed ID: 10868854
[TBL] [Abstract][Full Text] [Related]
28. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
[TBL] [Abstract][Full Text] [Related]
29. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans.
Luzi L; DeFronzo RA
Am J Physiol; 1989 Aug; 257(2 Pt 1):E241-6. PubMed ID: 2669517
[TBL] [Abstract][Full Text] [Related]
30. The continuous low dose insulin and glucose infusion test: a simplified and accurate method for the evaluation of insulin sensitivity and insulin secretion in population studies.
Piatti PM; Monti LD; Caumo A; Santambrogio G; Magni F; Galli-Kienle M; Costa S; Pontiroli AE; Alberti KG; Pozza G
J Clin Endocrinol Metab; 1995 Jan; 80(1):34-40. PubMed ID: 7829636
[TBL] [Abstract][Full Text] [Related]
31. Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity.
Mather KJ; Paradisi G; Leaming R; Hook G; Steinberg HO; Fineberg N; Hanley R; Baron AD
Diabetes Metab Res Rev; 2002; 18(2):118-26. PubMed ID: 11994903
[TBL] [Abstract][Full Text] [Related]
32. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.
Vauhkonen I; Niskanen L; Vanninen E; Kainulainen S; Uusitupa M; Laakso M
J Clin Invest; 1998 Jan; 101(1):86-96. PubMed ID: 9421470
[TBL] [Abstract][Full Text] [Related]
33. [A study of the degrees of insulin resistance and first-phase insulin secretion of beta-cells in metabolic syndrome patients with different glucose tolerance].
Hong J; Gu WQ; Zhang YF; Guo Y; Chen HM; Zhang LZ; Zhao YJ; Ning G
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1952-6. PubMed ID: 14703429
[TBL] [Abstract][Full Text] [Related]
34. [Effect of different dietary loads on glucose-dependent insulinotropic polypeptide in subjects with normal glucose tolerance].
Chen Z; Yan L; Fu XY; Yang HZ; Kuang J
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2031-4. PubMed ID: 22200706
[TBL] [Abstract][Full Text] [Related]
35. Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.
Henriksen JE; Alford F; Ward GM; Beck-Nielsen H
Diabetologia; 1997 Dec; 40(12):1439-48. PubMed ID: 9447952
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the minimal model and the hyperglycemic clamp for measuring insulin sensitivity and acute insulin response to glucose.
Korytkowski MT; Berga SL; Horwitz MJ
Metabolism; 1995 Sep; 44(9):1121-5. PubMed ID: 7666784
[TBL] [Abstract][Full Text] [Related]
37. Effect of FK506 on insulin secretion in normal dogs.
Strasser S; Alejandro R; Shapiro ET; Ricordi C; Todo S; Mintz DH
Metabolism; 1992 Jan; 41(1):64-7. PubMed ID: 1371575
[TBL] [Abstract][Full Text] [Related]
38. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis.
Kruszynska YT; Home PD; McIntyre N
Hepatology; 1991 Jul; 14(1):103-11. PubMed ID: 2066059
[TBL] [Abstract][Full Text] [Related]
39. Elevated basal insulin secretion and normal dynamic insulin sensitivity in borderline hypertension.
Piccardo MG; Turchetti G; Rosa MS; Pacini G
Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):244-9. PubMed ID: 10656171
[TBL] [Abstract][Full Text] [Related]
40. Evidence for direct action of alloxan to induce insulin resistance at the cellular level.
Ader M; Richey JM; Bergman RN
Diabetologia; 1998 Nov; 41(11):1327-36. PubMed ID: 9833941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
